Skip to main content

Table 2 Comparison of mean scores of cognitive assessment scales between MS patients and healthy controls

From: Clinical predictors to cognitive impairment in multiple sclerosis patients

Mean ± SD Patients (N = 45) Controls (N = 45) P value
ACE attention 16.7 ± 1.2 18.0 ± 0.0 < 0.001**
ACE memory 19.6 ± 2.3 24.5 ± 0.3 < 0.001**
ACE language 22.0 ± 2.3 25.2 ± 1.3 < 0.001**
ACE fluency 10.3 ± 1.7 12.6 ± 1.1 < 0.001**
ACE visuospatial 15.2 ± 1.1 16.0 ± 0.0 0.011*
ACE total 83.0 ± 5.7 95.5 ± 0. 4 < 0.001**
PASAT 3 21.9 ± 9.0 44.8 ± 7.8 < 0.001**
Trail making type B 191.3 ± 73.1 77.5 ± 6.0 < 0.001**
  1. *Significant
  2. **Highly significant
  3. ACE Addenbrooke’s cognitive examination III, PASAT3 Paced auditory serial addition test, N number, SD standard deviation
  4. P value is significant if ≤ 0.050